Clinical Trials Logo

Filter by:
NCT ID: NCT05730777 Not yet recruiting - Clinical trials for Cancer Therapy-related Cardiovascular Toxicity

Correlation Between Myocardial Injury and Intestinal Flora Changes Associated With Oncology Drug Therapy and the Preventive of Probiotics

Start date: February 15, 2023
Phase: Phase 4
Study type: Interventional

The purpose of this study was to explore the relationship between early myocardial injury caused by tumor drug therapy and intestinal microbial structure changes by echocardiographic two-dimensional speckle tracking technique and intestinal microflora structure detection. The investigators will also explore prevention and treatment through randomized controlled trials to initiate early intervention before clinical symptoms appear.

NCT ID: NCT05730764 Recruiting - Infertility Clinical Trials

A Prediction Model and Assisted Decision-making System of Fertilization Disorders

Start date: January 15, 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to test the accuracy of the forecasting system we develop. The main question it aims to answer is: - Whether the clinical prediction system predicts the incidence of fertilization disorders accurately. - The fertilization disorder prediction system predicts whether and how much the outcome differs from the doctor. Participants will receive treatment assisted by a predictive system or receive general treatment. Researchers will compare incidence of fertilization disorders to see if the fertilization disorder prediction system makes correct predictions.

NCT ID: NCT05730595 Not yet recruiting - Clinical trials for Colorectal Neoplasms

Fluorescence Laparoscopic Navigation for Rectal Cancer and Sigmoid Colon Cancer

FLORA-01
Start date: September 1, 2023
Phase: N/A
Study type: Interventional

To explore the short-term and long-term outcomes of fluorescence laparoscopic navigation D2 lymph node dissection for colorectal cancer surgery by comparing it with D3 lymph node dissection.

NCT ID: NCT05729737 Recruiting - Pancreatic Cancer Clinical Trials

Radiographic Response to Chemotherapy in Unresected Localized Pancreatic Cancer

Start date: January 1, 2022
Phase:
Study type: Observational [Patient Registry]

The goal of this observational study is to explore whether contrast-enhanced ultrasound (CEUS) can early predict and evaluate the treatment response of first-line chemotherapy in locally advanced and borderline resectable pancreatic cancers. The main questions it aims to answer are: Question 1: What quantitative parameters of CEUS performed before first-line chemotherapy can predict the early treatment response of patients with locally pancreatic cancer?Question 2: Can CEUS reflect early neovascular changes after first-line chemotherapy in pancreatic tumors? Participants will receive CEUS examination carried out by experienced operators before the first cycle of chemotherapy and after 2 treatment cycles.

NCT ID: NCT05729646 Recruiting - Clinical trials for Adenocarcinoma of the Stomach

Perioperative Chemotherapy Plus Toripalimab for dMMR Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma

Start date: May 31, 2023
Phase: Phase 2
Study type: Interventional

This study is a prospective, multi-center, randomized controlled phase II trial to compare the efficacy of perioperative SOX plus toripalimab, toripalimab monotherapy with SOX regimen in participants with dMMR locally advanced gastric or esophagogastric junction adenocarcinoma

NCT ID: NCT05729555 Not yet recruiting - Pain Clinical Trials

Comparative Pharmacokinetic (PK) Study of Ibuprofen and Diphenhydramine Hydrochloride MR Tablets in Healthy Adults Under Fasting Condition

Start date: April 3, 2023
Phase: Phase 1
Study type: Interventional

Ibuprofen and Diphenhydramine Hydrochloride Modified-Release Tablets were randomized, open, two-cycle Comparative pharmacokinetic test under double crossover and fasting condition. Main objective: Ibuprofen and Diphenhydramine Hydrochloride Modified-Release Tablets developed by Overseas Pharmaceuticals, Ltd.(Specification: each tablet containing ibuprofen 400 mg, Phenhenhydramine hydrochloride 50 mg) is the test preparation, JOHNSON & JOHNSON CONSUMER INC. Production (trade name: Motrin IB®, Specification: 200 mg) for comparative drug product 1, JOHNSON & JOHNSON CONSUMER INC. Hydrodramine hydrochloride (trade name: Benadryl®, Specification: 25 mg) for comparative formulation 2, In the fasting state, To investigate the pharmacokinetic parameters in healthy Chinese subjects of 1 and 2, And were compared. Secondary objective: To evaluate the safety of a single oral administration of Ibuprofen and Diphenhydramine Hydrochloride Modified-Release Tablets and reference 1 and reference 2 diphenhydramine hydrochloride tablets in fasting conditions in healthy Chinese subjects.

NCT ID: NCT05729464 Recruiting - Neoplasms Clinical Trials

Risk Factors and Prediction Model of Cancer-associated Venous Thromboembolism

Start date: December 23, 2022
Phase:
Study type: Observational

The purpose of this study is to identify risk factors of cancer-associated venous thrombosis and develop a prediction model to assist clinicians in tailoring anticoagulant therapy.

NCT ID: NCT05729399 Recruiting - Solid Tumor Clinical Trials

Clinical Study of Autologous Tumor-infiltrating Lymphocyte Injection (GT201) for Advanced Solid Tumors

Start date: September 14, 2022
Phase: Early Phase 1
Study type: Interventional

This study is a multi-center, single-arm phase I clinical trial. A total of 26~42 subjects (20 evaluable cases are expected) from 1 cohort will be enrolled in this study. An "autologous tumor-infiltrating lymphocyte therapy" dosing regimen consisting of lymphodepleting chemotherapy (FC regimen: cyclophosphamide + fludarabine), infusion of autologous tumor-infiltrating lymphocyte injection, and interleukin-2 injection will be used.The study process is divided into: screening period, sampling and production period, clearing and chemotherapy period, treatment and observation period, and follow-up period

NCT ID: NCT05729217 Active, not recruiting - Symptoms and Signs Clinical Trials

Long COVID Symptoms in SARS-CoV-2-positive Children in China

Start date: February 1, 2023
Phase:
Study type: Observational

The goal of this observational study is to learn about in children aged 6-18 years, after the acute phase of SARS-CoV-2 infection, the COVID symptoms or Long COVID symptoms to impact their daily activities. We aimed to investigate the prevalence of long-lasting symptoms, the duration and intensity of symptoms, quality of life, number of sick days or absences from school, and psychological and social outcomes. The participants will be asked to fill in Long COVID symptom burden questionnaires who had been infected with SARS-CoV-2 as self-reported PRC test or antigen test positive.

NCT ID: NCT05728788 Recruiting - Clinical trials for Cancer Therapy-related Cardiovascular Toxicity

Correlation Between Myocardial Injury and Intestinal Flora Changes Associated With Oncology Drug Therapy

Start date: July 1, 2022
Phase:
Study type: Observational

The purpose of this study was to explore the relationship between early myocardial injury caused by tumor drug therapy and intestinal microbial structure changes by echocardiographic two-dimensional speckle tracking technique and intestinal microflora structure detection.